Hardware Podcasts

087 - From Crime Reporting to Regulatory Affairs and On/Off The Record with Ferdous Al-Faruque

Let's Combinate · 31 May 2023 · 39m

What this episode covers

Ferdous Al-Faruque, known as Danny, Senior Editor at RAPS, discusses his transition from crime reporting to covering medical device and pharma regulations, including his work on FDA user fee negotiations and digital health. He explains the journalistic rules of engagement, detailing the distinctions between off-the-record, on-background, and on-deep-background conversations to protect sources while maintaining credibility. Al-Faruque also outlines his editorial process at RAPS, emphasizing the importance of independent reporting, ethical standards, and the operational challenges of covering complex regulatory trends like gene therapy and digital health with limited resources.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
RAPS
Tools
PGP, GPG
Also
FDA, EMA, Windows XP

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 49m

    #341: What NOT to say to FDA

    Mike Drues, a regulatory consultant and expert witness, joins host Etienne Nichols to discuss strategies for communicating with the FDA during inspections and pre-market reviews. Drues emphasizes the mantra 'tell, don't ask, lead, don't follow' and advises companies to manage FDA expectations by providing objective evidence of their processes rather than just citing procedures. He highlights the importance of being prepared for unannounced inspections, answering only the question asked, and using clarifying questions to buy time when necessary.

    Certification & complianceQuality & yield
    8 chapters

  • Global Medical Device Podcast · 37m

    Part 1: The Theranos Loophole & Lab Developed Tests

    Mike Drues, president of Vascular Sciences, explains the regulatory distinction between Lab Developed Tests (LDTs) and In Vitro Diagnostics (IVDs), noting that LDTs are currently exempt from FDA pre-market review under the guise of the 'practice of medicine.' He argues that this loophole, highlighted by the Theranos case, allows companies to bypass rigorous safety and efficacy testing, creating a double standard where hospitals face no oversight for modifying commercial devices while manufacturers do. Drues emphasizes that the VALID Act, which would bring LDTs under FDA jurisdiction, has been stalled in Congress despite bipartisan support, leaving a significant regulatory gap that risks patient safety.

    Certification & complianceMedical & health devices
    8 chapters

  • Global Medical Device Podcast · 34m

    Shaking Things Up: What's Next for the Global Medical Device Podcast

    Jon Speer, founder of Greenlight Guru, introduces Etienne Nichols, a medical device guru at Greenlight Guru, as the show's new co-host to bring fresh perspectives to the Global Medical Device Podcast. They discuss Greenlight Guru's 'Guru Edge'—a team of former industry professionals—and highlight trends like data-driven decision-making, the convergence of wellness wearables with medical devices, and the rise of home-use products. Etienne Nichols reflects on his evolving appreciation for FDA regulations as flexible guardrails rather than rigid constraints, contrasting modern collaborative interactions with the adversarial regulatory environment of the late 1990s.

    Connected products & IoTCertification & compliance
    9 chapters

  • Global Medical Device Podcast · 46m

    #340: LDTs & the FDAs Proposed Ruling

    Shannon Bennett, Director of Regulatory Affairs, joins host Etienne Nichols to dissect the FDA's October 2023 proposed rule to regulate Laboratory Developed Tests (LDTs) as medical devices. Bennett outlines the four-year phased implementation plan, detailing the shift from CLIA oversight to FDA requirements for adverse event reporting, registration, and Quality System Regulation (QSR) compliance. He highlights the massive administrative burden, estimating 80,000 to 100,000 submissions and $55 billion in annual industry costs, while discussing the potential disruption to patient access and the need for clear guidance on risk categorization and new test submissions.

    Policy, trade & tariffsCertification & compliance
    10 chapters

  • Global Medical Device Podcast · 40m

    How Jon Speer Met His Most Frequent Guest: Mike Drues

    Jon Speer, host of the Global Medical Device Podcast and founder of Greenlight Guru, revisits his 2014 origin story with Mike Drues, president of Vascular Sciences, to discuss their past debates on medical device design controls. They analyze the tension between following the literal letter of FDA regulations versus understanding their intent, arguing that many companies fail because they treat compliance as a checkbox exercise rather than a rigorous engineering process. The conversation highlights the danger of assuming users know their own needs, which stifles revolutionary product development in favor of evolutionary improvements, and emphasizes the critical importance of validating validation methods and addressing off-label use in risk management.

    Validation & product-market fitCertification & compliance
    6 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.